top of page

Overview

Critical Innovations is currently developing multiple medical devices toward regulatory clearance. The company focuses on task-shifting evidence-based interventions to earlier echelons of care and more general specialty levels, to simplify management and allow for rapid provision in emergency and combat environments. To date, the company has worked under more than 20 different Department of Defense awards from all three military branches charged with medical technology development (i.e. U.S. Army, Air Force, and Navy), including such agencies as the Air Force Medical Support Agency; Army Medical Research and Development Command; Defense Health Agency; and, Office of Naval Research. Contract types have included Small Business Innovation Research (SBIR), Joint Warfighter, and Other Transactional Authority. As a prime contractor, Critical Innovations currently has a 100% transition rate from Phase I to Phase II, as well as Phase II to Phase III, for all eligible SBIR programs.

Our Devices

Critical Innovations
- Dec 9, 2020
- 1 min read

Article published in the Journal of Surgical Research shows benefits of F.O.A.M.™ device

An article just published in the Journal of Surgical Research shows impressive benefits with F.O.A.M.™ deployment in a lethal, large-animal model of non-compressible abdominal bleeding. This is the first study to describe the use of a thermoresponsive foam to manage this important injury and it successfully demonstrated proof-of-concept feasibility. The intervention group demonstrated a significantly higher mean arterial pressure and an impressive trend toward improved survival (82% vs. 50% in controls). This injury pattern normally requires emergent surgery from a highly trained surgeon, while the F.O.A.M.™ device aims to shift intervention to earlier providers and settings. See full article here.

Article published in the Journal of Surgical Research shows benefits of F.O.A.M.™ device

Recent Posts